UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 283

Sortiert nach

Sporadic inclusion body myositis: A review of recent clinical advances and current approaches to diagnosis and treatment

Clinical neurophysiology, 2016-03, Vol.127 (3), p.1764-1773

2016

Volltextzugriff (PDF)

Precision Medicine through Antisense Oligonucleotide-Mediated Exon Skipping

Trends in pharmacological sciences (Regular ed.), 2018-11, Vol.39 (11), p.982-994

2018

Volltextzugriff (PDF)

Inclusion body myositis: current pathogenetic concepts and diagnostic and therapeutic approaches

Lancet neurology, 2007-07, Vol.6 (7), p.620-631

2007

Volltextzugriff (PDF)

Progress in the molecular pathogenesis and nucleic acid therapeutics for Parkinson's disease in the precision medicine era

Medicinal research reviews, 2020-11, Vol.40 (6), p.2650-2681

2020

Volltextzugriff (PDF)

Dermatomyositis, polymyositis and immune-mediated necrotising myopathies

Biochimica et biophysica acta, 2015-04, Vol.1852 (4), p.622-632

2015

Volltextzugriff (PDF)

Cationic Arginine-Rich Peptides (CARPs): A Novel Class of Neuroprotective Agents With a Multimodal Mechanism of Action

Frontiers in neurology, 2020-02, Vol.11, p.108-108

2020

Volltextzugriff (PDF)

Altered Gut Microbiome in Parkinson's Disease and the Influence of Lipopolysaccharide in a Human α-Synuclein Over-Expressing Mouse Model

Frontiers in neuroscience, 2019-08, Vol.13, p.839-839

2019

Volltextzugriff (PDF)

Brainstem ventilatory dysfunction: A plausible mechanism for dyspnea in Parkinson's Disease?

Movement disorders, 2020-03, Vol.35 (3), p.379-388

2020

Volltextzugriff (PDF)

Mitochondria and neuroprotection in stroke: Cationic arginine-rich peptides (CARPs) as a novel class of mitochondria-targeted neuroprotective therapeutics

Neurobiology of disease, 2019-01, Vol.121, p.17-33

2019

Volltextzugriff (PDF)

The changing spectrum of drug-induced myopathies

Acta myologica, 2020-12, Vol.39 (4), p.283-288

Mastaglia, Frank L.

2020

Volltextzugriff (PDF)

The longitudinal study of muscle changes with ultrasound: differential changes in idiopathic inflammatory myopathy subgroups

Rheumatology (Oxford, England), 2024-02, Vol.63 (2), p.490-497

2024

Volltextzugriff (PDF)

From data to diagnosis: how machine learning is revolutionizing biomarker discovery in idiopathic inflammatory myopathies

Briefings in bioinformatics, 2023-11, Vol.25 (1)

2023

Volltextzugriff (PDF)

Balancing Clinical Applicability and Scientific Depth in ML Models for MDA5-DM Prognosis

Briefings in bioinformatics, 2024-05, Vol.25 (4)

2024

Volltextzugriff (PDF)

Intronic NEFH variant is associated with reduced risk for sporadic ALS and later age of disease onset

Scientific reports, 2022-08, Vol.12 (1), p.14739-14739, Article 14739

2022

Volltextzugriff (PDF)

The relationship between muscle pain and fatigue

Neuromuscular disorders : NMD, 2012-12, Vol.22, p.S178-S180

Mastaglia, Frank L

2012

Volltextzugriff (PDF)

Inclusion body myositis: A review of clinical and genetic aspects, diagnostic criteria and therapeutic approaches

Journal of clinical neuroscience, 2015-01, Vol.22 (1), p.6-13

2015

Volltextzugriff (PDF)

Targeted Molecular Therapeutics for Parkinson's Disease: A Role for Antisense Oligonucleotides?

Movement disorders, 2022-11, Vol.37 (11), p.2184-2190

2022

Volltextzugriff (PDF)

Antisense oligonucleotide induction of progerin in human myogenic cells

PloS one, 2014-06, Vol.9 (6), p.e98306

2014

Volltextzugriff (PDF)

Impact of Gastrointestinal Symptoms on Health-Related Quality of Life in an Australian Parkinson’s Disease Cohort

Parkinson's disease, 2022-11, Vol.2022, p.1-8

2022

Volltextzugriff (PDF)

Neuroprotective Cationic Arginine-Rich Peptides (CARPs): An Assessment of Their Clinical Safety

Drug safety, 2020-10, Vol.43 (10), p.957-969

2020

Volltextzugriff (PDF)

Late-onset riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency (MADD): case reports and epidemiology of ETFDH gene mutations

BMC neurology, 2019-12, Vol.19 (1), p.330-330, Article 330

2019

Volltextzugriff (PDF)

Changes in the Gut Microbiome and Predicted Functional Metabolic Effects in an Australian Parkinson’s Disease Cohort

Frontiers in neuroscience, 2021-10, Vol.15, p.756951-756951

2021

Volltextzugriff (PDF)

High-resolution HLA genotyping in inclusion body myositis refines 8.1 ancestral haplotype association to DRB103:01:01 and highlights pathogenic role of arginine-74 of DRβ1 chain

Journal of autoimmunity, 2024-01, Vol.142, p.103150-103150, Article 103150

2024

Volltextzugriff (PDF)

Dyspnea in Parkinson's disease: an approach to diagnosis and management

Expert review of neurotherapeutics, 2020-06, Vol.20 (6), p.619-626

2020

Volltextzugriff (PDF)

Differential effects of sex on longitudinal patterns of cognitive decline in Parkinson’s disease

Journal of neurology, 2021-05, Vol.268 (5), p.1903-1912

2021

Volltextzugriff (PDF)

1 – 25 von 283

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(258)
Mit Volltextzugriff
(246)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(205)
Life Sciences & Biomedicine
(201)
Humans
(174)
Neurosciences & Neurology
(145)
Male
(116)
Female
(114)
Neurology
(105)
Neurosciences
(105)
Clinical Neurology
(99)
Middle Aged
(92)
Biological And Medical Sciences
(74)
Adult
(72)
Medical Sciences
(60)
Aged
(59)
Parkinson's Disease
(32)
Adolescent
(22)
Fundamental And Applied Biological Sciences. Psychology
(21)
Genotype
(21)
Inclusion Body Myositis
(21)
Magnetic Resonance Imaging
(21)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Sporadic inclusion body myositis: A review of recent clinical advances and current approaches to diagnosis and treatment

Precision Medicine through Antisense Oligonucleotide-Mediated Exon Skipping

Inclusion body myositis: current pathogenetic concepts and diagnostic and therapeutic approaches

Progress in the molecular pathogenesis and nucleic acid therapeutics for Parkinson's disease in the precision medicine era

Dermatomyositis, polymyositis and immune-mediated necrotising myopathies

Cationic Arginine-Rich Peptides (CARPs): A Novel Class of Neuroprotective Agents With a Multimodal Mechanism of Action

Altered Gut Microbiome in Parkinson's Disease and the Influence of Lipopolysaccharide in a Human α-Synuclein Over-Expressing Mouse Model

Brainstem ventilatory dysfunction: A plausible mechanism for dyspnea in Parkinson's Disease?

Mitochondria and neuroprotection in stroke: Cationic arginine-rich peptides (CARPs) as a novel class of mitochondria-targeted neuroprotective therapeutics

The changing spectrum of drug-induced myopathies

The longitudinal study of muscle changes with ultrasound: differential changes in idiopathic inflammatory myopathy subgroups

From data to diagnosis: how machine learning is revolutionizing biomarker discovery in idiopathic inflammatory myopathies

Balancing Clinical Applicability and Scientific Depth in ML Models for MDA5-DM Prognosis

Intronic NEFH variant is associated with reduced risk for sporadic ALS and later age of disease onset

The relationship between muscle pain and fatigue

Inclusion body myositis: A review of clinical and genetic aspects, diagnostic criteria and therapeutic approaches

Targeted Molecular Therapeutics for Parkinson's Disease: A Role for Antisense Oligonucleotides?

Antisense oligonucleotide induction of progerin in human myogenic cells

Impact of Gastrointestinal Symptoms on Health-Related Quality of Life in an Australian Parkinson’s Disease Cohort

Neuroprotective Cationic Arginine-Rich Peptides (CARPs): An Assessment of Their Clinical Safety

Late-onset riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency (MADD): case reports and epidemiology of ETFDH gene mutations

Changes in the Gut Microbiome and Predicted Functional Metabolic Effects in an Australian Parkinson’s Disease Cohort

High-resolution HLA genotyping in inclusion body myositis refines 8.1 ancestral haplotype association to DRB103:01:01 and highlights pathogenic role of arginine-74 of DRβ1 chain

Dyspnea in Parkinson's disease: an approach to diagnosis and management

Differential effects of sex on longitudinal patterns of cognitive decline in Parkinson’s disease

Suchergebnisse filtern